Articolo in rivista, 2020, ENG, 10.3390/ijms21155571
Verde, Valeria; Longo, Anna; Cucci, Lorena Maria; Sanfilippo, Vanessa; Magrì, Antonio; Satriano, Cristina; Anfuso, Carmelina Daniela; Lupo, Gabriella; La Mendola, Diego
Università di Pisa; Consiglio Nazionale delle Ricerche; Università degli Studi di Catania
Graphene oxide (GO) is a bidimensional novel material that exhibits high biocompatibility and angiogenic properties, mostly related to the intracellular formation of reactive oxygen species (ROS). In this work, we set up an experimental methodology for the fabrication of GO@peptide hybrids by the immobilization, via irreversible physical adsorption, of the Ac-(GHHPH)-NH peptide sequence, known to mimic the anti-angiogenic domain of the histidine-proline-rich glycoprotein (HPRG). The anti-proliferative capability of the graphene-peptide hybrids were tested in vitro by viability assays on prostate cancer cells (PC-3 line), human neuroblastoma (SH-SY5Y), and human retinal endothelial cells (primary HREC). The anti-angiogenic response of the two cellular models of angiogenesis, namely endothelial and prostate cancer cells, was scrutinized by prostaglandin E2 (PGE) release and wound scratch assays, to correlate the activation of inflammatory response upon the cell treatments with the GO@peptide nanocomposites to the cell migration processes. Results showed that the GO@peptide nanoassemblies not only effectively induced toxicity in the prostate cancer cells, but also strongly blocked the cell migration and inhibited the prostaglandin-mediated inflammatory process both in PC-3 and in HRECs. Moreover, the cytotoxic mechanism and the internalization efficiency of the theranostic nanoplatforms, investigated by mitochondrial ROS production analyses and confocal microscopy imaging, unraveled a dose-dependent manifold mechanism of action performed by the hybrid nanoassemblies against the PC-3 cells, with the detection of the GO-characteristic cell wrapping and mitochondrial perturbation. The obtained results pointed out to the very promising potential of the synthetized graphene-based hybrids for cancer therapy.
International journal of molecular sciences (Print) 21 (15), pp. 1–23
Cell migration, Confocal microscopy, HPRG, Human prostate cancer cells, Nanomaterials, Nanomedicine, Peptides, Prostaglandins, ROS, Theranostics
ID: 453292
Year: 2020
Type: Articolo in rivista
Creation: 2021-04-27 09:42:42.000
Last update: 2021-05-06 22:16:09.000
CNR authors
CNR institutes
External links
OAI-PMH: Dublin Core
OAI-PMH: Mods
OAI-PMH: RDF
DOI: 10.3390/ijms21155571
URL: http://www.scopus.com/record/display.url?eid=2-s2.0-85089170883&origin=inward
External IDs
CNR OAI-PMH: oai:it.cnr:prodotti:453292
DOI: 10.3390/ijms21155571
Scopus: 2-s2.0-85089170883